The Institute for Clinical and Economic Review is a health economics organization that assesses the value of new drugs, medical devices and diagnostics.
Though ICER is not a government entity, its decisions often impact medication coverage by public and private health plans. Nevertheless, patients, clinicians and caregivers lack meaningful opportunities to provide input on ICER’s value assessments.
